Literature DB >> 24042022

Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.

Kenichiro Miura1, Hidetake Kurihara, Shigeru Horita, Hiroko Chikamoto, Motoshi Hattori, Yutaka Harita, Haruko Tsurumi, Yuko Kajiho, Yoko Sawada, Satoshi Sasaki, Takashi Igarashi, Shinji Kunishima, Takashi Sekine.   

Abstract

BACKGROUND: Previous studies have identified significant associations between the development of idiopathic focal segmental glomerulosclerosis (FSGS) and MYH9 encoding nonmuscle myosin heavy chain-IIA (NMMHC-IIA). However, these studies focused only on the linkage of MYH9 polymorphisms and development of FSGS. There have been no reports on pathological changes of NMMHC-IIA in human glomerular diseases. Here we report on the precise localization of NMMHC-IIA in podocytes and changes in NMMHC-IIA expression in pathological states in rats and humans.
METHODS: Immunocytochemical (immunofluorescence and immunoelectron microscopy) studies were performed to determine the precise localization of NMMHC-IIA. Expression levels of NMMHC-IIA were investigated in puromycin aminonucleoside (PAN)-treated rats; and expression levels of NMMHC-IIA and other podocyte-related proteins were investigated in glomeruli of patients with idiopathic FSGS and other heavy proteinuric glomerular diseases.
RESULTS: NMMHC-IIA was located primarily at the cell body and primary processes of podocytes; this localization is distinct from other podocyte-related molecules causing hereditary FSGS. In PAN-treated rat kidneys, expression levels of NMMHC-IIA in podocytes decreased. Immunohistochemical analysis revealed that expression levels of NMMHC-IIA markedly decreased in idiopathic nephrotic syndrome, especially FSGS, whereas it did not change in other chronic glomerulonephritis showing apparent proteinuria. Changes in NMMHC-IIA expression were observed in glomeruli where expression of nephrin and synaptopodin was maintained.
CONCLUSIONS: Considering previous genome-wide association studies and development of FSGS in patients with MYH9 mutations, the characteristic localization of NMMHC-IIA and the specific decrease in NMMHC-IIA expression in idiopathic nephrotic syndrome, especially FSGS, suggest the important role of NMMHC-IIA in the development of FSGS.

Entities:  

Keywords:  focal segmental glomerulosclerosis; myh9; nonmuscle myosin heavy chain-IIA; podocyte; primary process

Mesh:

Substances:

Year:  2013        PMID: 24042022     DOI: 10.1093/ndt/gft350

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  8 in total

Review 1.  The role of Slit-Robo signaling in the regulation of tissue barriers.

Authors:  Ming-Fang Wu; Chen-Yi Liao; Ling-Yi Wang; Jinghua Tsai Chang
Journal:  Tissue Barriers       Date:  2017-06-08

2.  Injury-induced actin cytoskeleton reorganization in podocytes revealed by super-resolution microscopy.

Authors:  Hani Y Suleiman; Robyn Roth; Sanjay Jain; John E Heuser; Andrey S Shaw; Jeffrey H Miner
Journal:  JCI Insight       Date:  2017-08-17

3.  Nonmuscle myosin 2 proteins encoded by Myh9, Myh10, and Myh14 are uniquely distributed in the tubular segments of murine kidney.

Authors:  Karla L Otterpohl; Ryan G Hart; Claire Evans; Kameswaran Surendran; Indra Chandrasekar
Journal:  Physiol Rep       Date:  2017-12

Review 4.  Non-Muscle Myosin 2A (NM2A): Structure, Regulation and Function.

Authors:  Cláudia Brito; Sandra Sousa
Journal:  Cells       Date:  2020-07-01       Impact factor: 6.600

Review 5.  Non-muscle myosin II in disease: mechanisms and therapeutic opportunities.

Authors:  Karen A Newell-Litwa; Rick Horwitz; Marcelo L Lamers
Journal:  Dis Model Mech       Date:  2015-11-05       Impact factor: 5.758

6.  Effect of donor non-muscle myosin heavy chain (MYH9) gene polymorphisms on clinically relevant kidney allograft dysfunction.

Authors:  Joanna Pazik; Monika Oldak; Dominika Oziębło; Dominika Dęborska Materkowska; Anna Sadowska; Jacek Malejczyk; Magdalena Durlik
Journal:  BMC Nephrol       Date:  2020-09-01       Impact factor: 2.388

7.  Two Cases of the MYH9 Disorder Fechtner Syndrome Diagnosed from Observation of Peripheral Blood Cells before End-Stage Renal Failure.

Authors:  Shin Teshirogi; Jun Muratsu; Hidenori Kasahara; Ken Terashima; Sho Miki; Tomohiro Minami; Yujiro Okute; Suguru Yoneda; Atsuyuki Morishima; Shinji Kunishima; Katsuhiko Sakaguchi
Journal:  Case Rep Nephrol       Date:  2019-11-26

8.  Conditional Myh9 and Myh10 inactivation in adult mouse renal epithelium results in progressive kidney disease.

Authors:  Karla L Otterpohl; Brook W Busselman; Ishara Ratnayake; Ryan G Hart; Kimberly R Hart; Claire M Evans; Carrie L Phillips; Jordan R Beach; Phil Ahrenkiel; Bruce A Molitoris; Kameswaran Surendran; Indra Chandrasekar
Journal:  JCI Insight       Date:  2020-11-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.